epinastine has been researched along with Liver Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, Y; Jian, YL; Jin, Y; Qin, X; Wang, MT; Wang, ZD; Xu, XF; Yang, HY; Yang, YX; Zhang, ZR; Zhao, CY | 1 |
1 other study(ies) available for epinastine and Liver Diseases
| Article | Year |
|---|---|
In vivo biodistribution, anti-inflammatory, and hepatoprotective effects of liver targeting dexamethasone acetate loaded nanostructured lipid carrier system.
Topics: Animals; Anti-Inflammatory Agents; Carbon Tetrachloride; Carrageenan; Dexamethasone; Drug Carriers; In Vitro Techniques; Liposomes; Liver; Liver Diseases; Mice; Nanomedicine; Nanoparticles; Rats; Rats, Wistar; Tissue Distribution | 2010 |